The abstract is read at the publisher; the summary is JClub's.
Genetically encoded intracellular binders expand access to the human proteome by enabling selective recognition, imaging, and functional modulation of endogenous proteins in living cells.
- Why it matters: Many disease-relevant proteins are inaccessible to conventional small molecules or extracellular antibodies, limiting targeted control in cancers, neurodegenerative disorders, and infectious diseases.
- What they did: The work reviews modular intracellular binder platforms—nanobodies, DARPins, affibodies, and de novo scaffolds—covering structural diversity, discovery/design principles, and computationally assisted optimization.
- The result: It summarizes emerging preclinical applications for imaging, biosensing, and targeted protein control, and highlights translational hurdles such as cellular stability, delivery, and immunogenicity for future therapeutics.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.